摩根大通于2026年9月4日以每股均价192.0824港元卖出药明康德股份61.99万股,涉资约1.19亿港元。
摩根大通此次减持前持有药明康德好仓5389.93万股,占比10.14%;减持后持股量为5327.94万股,好仓比例降至9.9%。
摩根大通于2026年9月4日以每股均价192.0824港元卖出药明康德股份61.99万股,涉资约1.19亿港元。
摩根大通此次减持前持有药明康德好仓5389.93万股,占比10.14%;减持后持股量为5327.94万股,好仓比例降至9.9%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.